At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Probioticdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of the Role of Probiotics in Prevention of Ventilator-Associated Pneumonia in Neonates
In Brief
A clinical study evaluating Probiotic for Ventilator Acquired Pneumonia. Completed, enrolled 80 participants across 1 site.
Detailed Summary
Evaluate the preventive value of probiotics on VAP among ventilated neonates.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVentilator Acquired Pneumonia
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartMay 2023
Primary CompletionMay 2024
Study CompletionJun 2024
First PostedJun 2025
TodayJul 2026
First PostedJun 3, 2025
Enrollment StartMay 1, 2023
Primary CompletionMay 1, 2024
Study CompletionJun 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 1.1 years ago
Interventions
Probioticdietary
Probiotic sachets contained 1× 109 colony-forming unit of Bifidobacterium Animalis subsp.lactis BB-12), were given via orogastric tube twice daily.